Katrin A. Becker
Kerpener Str. 62
Koeln, NW 50937, Germany
Koeln, NW 50937, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 90 publications
Amitriptyline potently neutralizes distinct SARS-CoV-2 variants including D614G, Omicron BA.5, and Omicron XBB.1.
Journal: Frontiers in microbiology
Published: May 20, 2025
Inflammatory stimuli impact on cellular uptake and biodistribution of perfluorocarbon nanoemulsions.
Inflammatory stimuli impact on cellular uptake and biodistribution of perfluorocarbon nanoemulsions.
Journal: Journal of leukocyte biology
Published: August 04, 2024
Fluoxetine and Sertraline Potently Neutralize the Replication of Distinct SARS-CoV-2 Variants.
Journal: Viruses
Published: February 15, 2024
Animal Welfare Aspects in Planning and Conducting Experiments on Rodent Models of Subarachnoid Hemorrhage.
Journal: Cellular and molecular neurobiology
Published: July 31, 2023
Medications Modulating the Acid Sphingomyelinase/Ceramide System and 28-Day Mortality among Patients with SARS-CoV-2: An Observational Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 26, 2023
CD73 deficiency does not aggravate angiotensin II-induced aortic inflammation in mice.
Journal: Scientific reports
Published: May 09, 2023
Acid sphingomyelinase expression is associated with survival in resectable pancreatic ductal adenocarcinoma.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: January 19, 2023
Simultaneous targeting of mitochondrial Kv1.3 and lysosomal acid sphingomyelinase amplifies killing of pancreatic ductal adenocarcinoma cells in vitro and in vivo.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: November 25, 2022
Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19.
Journal: Journal of clinical medicine
Published: September 09, 2022
Last Updated: 09/26/2026